Haier Biomedical Advances Childhood Cancer Research In Australia

Haier Biomedical has recently delivered its cryogenic storage solutions to the Centre for Childhood Cancer Research in Australia, marking a major cross-ocean collaboration between technology and life-saving science. Through technological innovation and this partnership, Haier Biomedical is reinforcing its commitment to supporting global childhood health.

Partnering with a World-Leading Institution to Protect Childhood Health

As an internationally-recognized authority in childhood cancer research, the Centre for Childhood Cancer Research has long been committed to advancing research in the diagnosis, treatment, and prevention of childhood cancer.

As part of this partnership, Haier Biomedical has supplied 6 Liquid Nitrogen Containers and 11 UltraEco ULT Freezers, providing critical infrastructure to support the institute’s biomedical research, helping accelerate progress in childhood cancer studies.

Outstanding Performance, Precisely Matched to Research Needs

With advanced technical capabilities and precise application-focused design, Haier Biomedical’s products provide comprehensive support for childhood cancer research.

Liquid Nitrogen Containers—Efficient, Safe, and Streamlined Sample Management: Each unit is equipped with a 360° rotating tray system to ensure uniform internal temperature distribution, and modular 4-6 sector compartment design that enables independent labeling, significantly improving sample access efficiency. They also feature dual liquid-and vapor-phase storage modes, with vapor-phase storage effectively reducing the risk of sample cross-contamination, as well as advanced CryoSmart intelligent monitoring system, equipped with high-precision temperature and liquid-level sensors to provide real-time, continuous monitoring of storage conditions, ensuring sample integrity.

UltraEco ULT Freezers—Green, Energy-Efficient Technology Setting New Standards in Scientific Research: Featuring environmentally friendly hydrocarbon refrigerants and LAB foaming agents, each unit reduces carbon dioxide emissions by approximately 2,269kg per year. With minimum daily energy consumption as low as 4.97kWh/24h, its energy efficiency performance ranked among the top performers under U.S. ENERGY STAR certification, delivering 30% to 50% energy savings compared to similar products, thereby earning the moniker of an “Energy-Efficient Pioneer” supporting greener research environments.

Driven by the belief that every child deserves a healthy future, Haier Biomedical continues to invest in technological innovation that safeguards life at its earliest stages, building a strong foundation for global childhood health initiatives—ensuring that technology not only crosses borders, but also makes a difference for children everywhere.